24/7 Market News (NASDAQ: APEN) APOLLO ENDOSURGERY INC. has received news this morning that has shares up more than 17% on 1700 plus trades and light volume.
The company is trading at $5.03 and looks to improve on FDA news.
FDA Grants De Novo Marketing Authorization to Apollo Endosurgery for Apollo ESG(TM) and Apollo REVISE(TM), New Endoscopic Systems for Patients with Obesity